Amgen’s Chairman and CEO Bob Bradway discussed how artificial intelligence is transforming biotechnology and scientific discovery on Bain & Company’s Winning with AI podcast. He highlighted that “AI is fundamentally changing how medicines are discovered, developed, manufactured and delivered to patients.” The conversation explored why Amgen invested early in AI and data science, along with strategies for implementing organizational transformation at scale.